Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Board & Shareholder Meetings View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.3%1-day move

₹162.00

prior close

₹160.34

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.0———-1.3+1.8+13.3+10.9+13.6+9.3+10.7+4.8+9.9—

Up moveDown movePending

AI summary

Piramal Pharma Limited has disclosed the schedule of an upcoming analyst and institutional investor meeting. The company will participate in the 360 ONE Capital (B&K) 16th Annual Investor Conference - Trinity India 2026 on 27th May 2026 in Mumbai. The meeting will be held as a group or one-on-one investor conference format. The company has noted that dates are subject to change due to exigencies on the part of investors or the company. This filing is made under Regulation 30(6) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, which mandates disclosure of such scheduled investor interactions.

Likely market impact

This is a routine regulatory compliance filing and does not contain any material financial or business information. It has no direct impact on the stock price or shareholder interests.